CAZZAGON, NORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.012
EU - Europa 1.008
AS - Asia 695
SA - Sud America 17
AF - Africa 12
OC - Oceania 6
Totale 6.750
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.996
IT - Italia 396
SG - Singapore 346
CN - Cina 229
DE - Germania 102
GB - Regno Unito 73
FI - Finlandia 72
FR - Francia 68
HK - Hong Kong 55
RU - Federazione Russa 53
SE - Svezia 50
NL - Olanda 29
ES - Italia 26
IE - Irlanda 22
UA - Ucraina 21
PL - Polonia 17
AT - Austria 15
IN - India 15
BR - Brasile 12
EG - Egitto 10
JP - Giappone 9
RO - Romania 9
RS - Serbia 9
CA - Canada 8
LV - Lettonia 8
MX - Messico 7
PK - Pakistan 7
AU - Australia 6
CY - Cipro 6
NO - Norvegia 6
AR - Argentina 5
CH - Svizzera 5
EE - Estonia 5
GR - Grecia 5
VN - Vietnam 5
AE - Emirati Arabi Uniti 3
BE - Belgio 3
BG - Bulgaria 3
IL - Israele 3
IQ - Iraq 3
TR - Turchia 3
CZ - Repubblica Ceca 2
HR - Croazia 2
HU - Ungheria 2
ID - Indonesia 2
PS - Palestinian Territory 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
DK - Danimarca 1
KG - Kirghizistan 1
LT - Lituania 1
MA - Marocco 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
SC - Seychelles 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
Totale 6.750
Salva come PNG Salva come JPEG
Città #
Fairfield 919
Woodbridge 495
Houston 397
Ashburn 370
Chandler 363
Seattle 316
Cambridge 311
Ann Arbor 281
Wilmington 251
Singapore 238
Boardman 126
San Diego 111
Padova 109
Santa Clara 93
Beijing 78
Princeton 77
Medford 76
Jacksonville 62
Des Moines 58
Hong Kong 55
Roxbury 49
Milan 43
Helsinki 35
Nanjing 31
Rome 29
London 26
Dublin 22
Madrid 19
New York 15
Guangzhou 13
Amsterdam 12
Nuremberg 11
Paris 11
Cairo 10
Frankfurt am Main 10
Belgrade 9
Palermo 9
Shenyang 9
Tianjin 9
Bucharest 8
Lappeenranta 8
Mysiadło 8
Redwood City 8
Riga 8
Stockholm 8
Verona 8
Cagliari 7
Dordives 7
Vienna 7
Bologna 6
Falls Church 6
Los Angeles 6
Mexico City 6
Nicosia 6
Norwalk 6
Oslo 6
Santa Maria di Sala 6
Brendola 5
Buenos Aires 5
Dong Ket 5
Hirakata 5
Hounslow 5
Kyiv 5
Reggio Emilia 5
Sahiwal 5
Sydney 5
Tallinn 5
Treviso 5
Hebei 4
Jiaxing 4
Jinan 4
Las Vegas 4
Parma 4
Salerno 4
Warsaw 4
Aix-en-Provence 3
Athens 3
Baghdad 3
Bari 3
Bergamo 3
Borås 3
Bosio 3
Brescia 3
Bulgarograsso 3
Dallas 3
Detroit 3
Hangzhou 3
Kharkiv 3
Mestre 3
Nanchang 3
Ningbo 3
Nole 3
North Bergen 3
Pont-Sainte-Marie 3
Quartu Sant'Elena 3
Salamanca 3
Shanghai 3
Sofia 3
Taizhou 3
Tampa 3
Totale 5.441
Salva come PNG Salva come JPEG
Nome #
UNIGASTRO : Malattie dell' Apparato Digerente . Edizione 2022 - 2025 ( Versione Italiana ) Capitolo: Epatite autoimmune 298
Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis 164
Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload. 146
Extrahepatic autoimmunity in autoimmune liver disease 146
Coronary flow reserve in patients with primary biliary cholangitis 143
Primary biliary cirrhosis: overlaps with other autoimmune disorders 142
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 140
Metabolic Syndrome Associated With Primary Biliary Cirrhosis. 138
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study 132
Extrahepatic Malignancies in Primary Biliary Cirrhosis: A Comparative Study at Two European Centers. 129
Thyroid Dysfunction in Primary Biliary Cholangitis: A Comparative Study at Two European Centers 126
The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis. 120
The prognostic role of magnetic resonance imaging in Primary Sclerosing Cholangitis 119
A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. 116
Molecular targeted therapy in hepatocellular carcinoma: present achievements and future challenges. 108
Diagnostic and Prognostic Role of Scca-IgM Serum Levels in Hepatocellular Carcinoma (Hcc). 108
P.16.3 THE PROGNOSTIC ROLE OF MAGNETIC RESONANCE CHOLANGIOGRAPHY IN PSC 107
Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres. 107
PERFORMANCE OF SURROGATE MARKERS OF HEPATIC FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 105
PERFORMANCE OF SURROGATE MARKERS OF HEPATIC FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 104
Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. 104
Retreatment of patients with chronic hepatitis C relapsers to a previous antiviral treatment. 101
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 101
Morning bright light treatment for sleep-wake disturbances in primary biliary cholangitis: A pilot study 99
New therapies for primary biliary cirrhosis 96
New Organ-Specific Drug Strategies Interfering in Signaling Pathways: Kinase Inhibitors and Other New Developmental Drugs in HCC 94
null 93
PERFORMANCE OF TRANSIENT ELASTOGRAPHY AND NON INVASIVE MARKERS OF LIVER FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 92
Extrahepatic Autoimmune Conditions Associated with Primary Biliary Cirrhosis. 92
Female patients in fertile age with chronic hepatitis C, easy genotype, and persistently normal transaminases have a 100% chance to reach a sustained virological response. 91
The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis 90
A novel HER2-targeted liposomal formulation for reducing the risk of liposome-induced hepatotoxicity 90
Pregnancy and Primary Biliary Cirrhosis: A Case-Control Study 89
PERFORMANCE OF TRANSIENT ELASTOGRAPHY AND NON INVASIVE MARKERS OF LIVER FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 88
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 87
P.1.158: PEG-INTERFERON ALPHA-2A WITH WEIGHT-BASED RIBAVIRIN DOSES IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES: A PILOT STUDY IN A SINGLE CENTRE 85
Hepatic Stem/Progenitor Cell Activation Differs between Primary Sclerosing and Primary Biliary Cholangitis 83
Incidence and risk factors for extra-hepatic malignancies in primary biliary cirrhosis: A comparative study from two European referral centers 82
Sleep-wake profiles in patients with primary biliary cirrhosis 82
Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis 81
Predictive criteria of response to endoscopic treatment for severe strictures in primary sclerosing cholangitis 79
PBC and related extrahepatic diseases 78
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis 75
Hepatitis B virus-related hepatocellular carcinoma: primary, secondary, and tertiary prevention. 74
Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from 20-year multicentre experience in Italy 72
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 72
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis 71
Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options 67
Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study 67
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis 67
Proposed therapies in primary biliary cholangitis 65
DIAGNOSTIC AND PROGNOSTIC ROLE OF SCCA-IgM IN HEPATOCELLULAR CARCINOMA (HCC) 64
A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis 63
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 63
INCIDENCE AND RISK FACTORS FOR EXTRA-HEPATIC MALIGNANCIES (EM) IN PRIMARY BILIARY CIRRHOSIS: A COMPARATIVE STUDY FROM TWO EUROPEAN REFERRAL CENTERS 62
Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis 61
METABOLIC SYNDROME INDUCES A MORE RAPID PROGRESSION OF FIBROSIS IN PRIMARY BILIARY CIRRHOSIS IN EARLY STAGE 57
Recommendations on the use of magnetic resonance imaging for collaborative multicenter studies in PSC 56
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis 52
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach 48
Primary biliary cholangitis: treatment 47
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival 47
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? 44
Gene expression profile in intrahepatic cholestasis of pregnancy. 44
Gene expression profile in intrahepatic cholestasis of pregnancy. 44
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 44
Primary biliary cholangitis: Perception and expectation of illness in Italian patients 44
Easl Clinical Practice Guidelines (Cpgs) On Non-Invasive Tests For Evaluation Of Liver Disease Severity And Prognosis- 2020 Update 43
Pathology of autoimmune hepatitis 43
Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitis 42
Letter: the use of magnetic resonance scores (Anali) for risk stratification in PSC 42
Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitis 41
Validation, clinical utility and limitations of the Amsterdam-Oxford model for primary sclerosing cholangitis 38
Pregnancy and primary biliary cirrhosis: A case–control study 37
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 37
Rate of Spleen Length Progression Is a Marker of Outcome in Patients With Primary Sclerosing Cholangitis 36
Pathology of non-alcoholic fatty liver disease 33
The phenolic compounds tyrosol and hydroxytyrosol counteract liver fibrogenesis via the transcriptional modulation of NADPH oxidases and oxidative stress-related miRNAs 31
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool 29
Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury 29
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 25
Reply to: Correspondence on "EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update" 22
UNIGASTRO: Digestive Diseases. 2022 - 2025 Edition (English Version) Chapter: Autoimmune Hepatitis 20
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 17
Impact on follow-up strategies in patients with primary sclerosing cholangitis 17
The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight 17
Liver Immunology, Principles and Practice, Third Edition Chapter 24: Primary Biliary Cholangitis: Autoimmune Hepatitis Overlap Syndrome 15
Overlap syndrome 14
Non-contrast MR lymphography of the lymphatic system of the liver 13
Pregnancy and Diseases of the Biliary Tree 13
Protective potential of the gallbladder in primary sclerosing cholangitis 13
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe 12
Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis 11
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis 10
Primary Sclerosing Cholangitis: Diagnostic Criteria 10
Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationship 9
Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group 9
Greater Transplant-free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls 9
In‐Hospital Screening Campaign Against Hepatitis C Could Be Effective for Identifying More Patients Who Still Need Treatment 9
Patient-reported quality of care in primary sclerosing cholangitis 8
Totale 6.899
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.075
article - articoli 29.176
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.379
Totale 61.630
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020403 0 0 0 0 0 0 0 105 107 102 45 44
2020/20211.092 37 50 168 161 58 33 31 123 122 150 122 37
2021/20221.246 85 82 163 57 69 141 80 96 94 56 87 236
2022/2023895 149 80 13 96 102 153 47 65 102 3 78 7
2023/2024743 25 61 46 54 64 92 123 50 39 35 65 89
2024/20251.058 20 207 101 80 229 85 117 219 0 0 0 0
Totale 6.945